Company Overview and News

 
[Press] Seventh Month High Oil Output in Indonesia for Australia's Bass Oil

2018-10-12 oilvoice
September production volumes totaled 17,081 barrels of oil (JV share) or 9,395 barrels (net to Bass), a 53% increase over August production
PBEGF BAS

 
[Press] Cash Payment for Bass Oil in Part Settlement of Royalty Dispute

2018-10-04 oilvoice
Australian oil company, Bass Oil Ltd (Bass) (ASX:BAS) is pleased to announce a negotiated settlement of a royalty dispute between Bass and one of the parties to the dispute (“Settlement Party”) and the associated termination of the royalty as between Bass and that Settlement Party.
BAS

 
[Press] Melbourne's Bass Eyes Strong FY Oil Production After Repairs Completed to Onshore Indonesian Wells

2018-09-13 oilvoice
Continuing high monthly average oil price of US$67.64 realised from sales from theCompany's 55%-owned Tangai-Sukananti oil field in onshore Sumatra, Indonesia
BAS

 
RIU GoodOilConference Perth to open with financing perspective from Westpac’s Mark Beeley

2018-09-12 proactiveinvestors.com.au
RIU GoodOilConference Perth will deliver more good oil for the industry during day two of the event, as Westpac Banking Corp’s (ASX:WBC) (NZE:WBC) (FRA:WBC) (NYSE:WBK) Westpac Institutional Bank energy and resources director Mark Beeley opens with a talk on Financing Considerations.
FAR TEG SXA SSLZY SGC MEL LCK BAS ICN ROG BRNGF MUR ICNOF COPJF AGYYF FARYF COE WBC CUEYF NWE STRXD STO WEBNF STRXF ELXPF WBK CUE CUEYY AJQ WBC OIEXF EXR KEY OEX BRU

 
RIU GoodOilConference Perth opens with financing perspective from Westpac’s Mark Beeley

2018-09-12 proactiveinvestors.com.au
RIU GoodOilConference Perth will deliver more good oil for the industry during day two of the event, as Westpac Banking Corp’s (ASX:WBC) (NZE:WBC) (FRA:WBC) (NYSE:WBK) Westpac Institutional Bank energy and resources director Mark Beeley opens with a talk on Financing Considerations.
FAR TEG SXA SSLZY SGC MEL LCK BAS ICN ROG BRNGF MUR ICNOF COPJF AGYYF FARYF COE WBC CUEYF NWE STRXD STO WEBNF STRXF ELXPF WBK CUE CUEYY AJQ WBC OIEXF EXR KEY OEX BRU

 
[Press] Bass Oil Half-Year Report

2018-09-07 oilvoice
As an Australian ASX-listed company, Bass Oil (ASX:BAS) has a focus, along with our Indonesian-based field teams and partners, on expanding onshore oil production from our onshore holdings in Indonesia'sprolific South Sumatran Basin. The principal asset is a 55% Operator interest in the long-life Tangai- Sukananti licence hosting multiple in-field exploration & production options.
BAS

 
RIU GoodOilConference Perth and WA Petroleum Day to put oil and gas players centre stage

2018-09-07 proactiveinvestors.com.au
The RIU GoodOilConference in Perth next week will focus on the current state of the oil and gas industry, and the explorers and producers operating in Australia.
FAR TEG HZN SXA SGC SRNLY LIO TAOIF BAS ICN BEPTF MUR COMRF CPTLY COPJF AGYYF NWE STRXD STRXF CUE ADX CTP EXR HZR BRU PCL CVN TAO SUR MEL LCK HZNFF ROG LIOEF BRNGF ICNOF FARYF COE CUEYF COI ADXRF ELXPF BCHEY CVONF CUEYY BPT AJQ RLE OIEXF CVX KEY OEX

 
[Press] Bass Oil: Budget Approved For Two New Onshore Indonesian Oil Wells

2018-08-28 oilvoice
Australian-listed, Indonesian oil producer, Bass Oil Limited (ASX:BAS) is pleased to announce that the Company has received formal approval from Indonesia's State-owned oil and natural gas corporation, PT Pertamina, for the budget to drill two onshore development oil wells, Bunian 5 and Tangai 5, from December this year in Bass's onshore oil fields in southern Sumatra.
BAS

 
[Press] Bass Oil: Onshore Indonesian Oil Operations Update – July 2018

2018-08-17 oilvoice
Continuing high monthly average oil price of US$68.52 realised on sales from theCompany's 55%-owned Tangai-Sukananti oil field in onshore Sumatra, Indonesia
BAS

 
[Press] Bass Oil: Quarterly Report for the Period Ending 30 June 2018

2018-07-27 oilvoice
Australia's ASX-listed Bass Oil (ASX:BAS) has a focus, along with its Indonesian-based field teams and partners, on expanding onshore oil production from its holdings in Indonesia's prolific South Sumatran Basin. The principal asset is a 55% Operator interest in the long-life Tangai-Sukananti licence hosting multiple in-field exploration & production options.
COPJF COE BAS

 
[Press] Bass Oil: Onshore Indonesian Oil Operations Update – June 2018

2018-07-20 oilvoice
Continuing high monthly average oil price of US$68.54 realised from sales from theCompany's 55%-owned Tangai-Sukananti oil field in onshore Sumatra, Indonesia
BAS

 
[Press] Bass Oil Extension of Acquisition Settlement Terms With Cooper Energy

2018-07-02 oilvoice
Australian oil producer, Bass Oil Limited (ASX: BAS), advises that the Company has negotiated an extension to the settlement terms with Cooper Energy Limited (ASX: COE) regarding the acquisition of its 55% interest in the Tangai-Sukananti KSO in South Sumatra.
COPJF COE BAS

 
[Press] Bass Oil: Onshore Indonesian Oil Operations Update – May 2018

2018-06-20 oilvoice
New multi-year high monthly average oil price of US$70.51 realised from sales from theCompany's 100%-owned Tangai-Sukananti oil field in onshore Sumatra, Indonesia
BAS

 
[Press] Australia's Bass Hungry for More Onshore Indonesian Oil Acquisitions After Record March Production from Sumatran Field

2018-04-09 oilvoice
Record March output as Indonesian oil field production lifts ~21% on February levels as a result of optimisation work
BAS

 
[Press] 20% Lift in Daily Indonesian Oil Output for Melbourne's Bass Oil

2018-04-04 oilvoice
Bass realises significant 20% uplift in daily field output at onshore oil production assets in South Sumatra
BAS

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to ASX:BAS / BASS STRAIT OIL COMPANY LIMITED on message board site Silicon Investor.

Major League Baseball (MLB) Major League Baseball (MLB) Major League Baseball (MLB) Anything graphite based, CCB, Zen and hopefully much more. Anything graphite based, CCB, Zen and hopefully much more. Anything graphite based, CCB, Zen and hopefully much more.
The Microcap Basement The Microcap Basement The Microcap Basement Universal basic income (UBI) Universal basic income (UBI) Universal basic income (UBI)
LyondellBasell Industries NV (LYB) LyondellBasell Industries NV (LYB) LyondellBasell Industries NV (LYB) Hemp based foods from Naturally Splendid Enterprises Ltd. Hemp based foods from Naturally Splendid Enterprises Ltd. Hemp based foods from Naturally Splendid Enterprises Ltd.
Basketball Junkie Forum (NBA) Basketball Junkie Forum (NBA) Basketball Junkie Forum (NBA) 2018 NCAA College Basketball March Madness 2018 NCAA College Basketball March Madness 2018 NCAA College Basketball March Madness
2017 NCAA College Basketball March Madness 2017 NCAA College Basketball March Madness 2017 NCAA College Basketball March Madness Hunteru0027s Basin Hunteru0027s Basin Hunteru0027s Basin